|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-4-30
|
|
pubmed:abstractText |
The present study was undertaken to see whether the difference in plasma cortisol suppression between single and repeated dosing of fluticasone propionate (FP) can be explained by systemic accumulation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
155-61
|
|
pubmed:dateRevised |
2009-10-2
|
|
pubmed:meshHeading |
pubmed-meshheading:9131947-Administration, Inhalation,
pubmed-meshheading:9131947-Adult,
pubmed-meshheading:9131947-Androstadienes,
pubmed-meshheading:9131947-Anti-Allergic Agents,
pubmed-meshheading:9131947-Anti-Asthmatic Agents,
pubmed-meshheading:9131947-Biological Availability,
pubmed-meshheading:9131947-Female,
pubmed-meshheading:9131947-Humans,
pubmed-meshheading:9131947-Hydrocortisone,
pubmed-meshheading:9131947-Reference Values
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.
|
|
pubmed:affiliation |
Astra Draco AB, Lund, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
